Prevalence of Substandard Amoxicillin Oral Dosage Forms in the National Capital District of Papua New Guinea

View More View Less
  • 1 Pharmacy, College of Medicine and Dentistry, James Cook University, Townsville, Australia;
  • 2 Division of Basic Medical Sciences, Pharmacology, University of Papua New Guinea, Port Moresby, Papua New Guinea

Antibiotics are commonly reported as being substandard or falsified in low- to middle-income countries, having potential to contribute to the development of antimicrobial resistance and drug-resistant infections. Amoxicillin, used to treat a number of infections and listed by the WHO as an essential medicine, presented as a good drug candidate for this study. We aimed to measure the prevalence of substandard and falsified amoxicillin oral products (tablets, capsules, and suspensions) in the National Capital District of Papua New Guinea (PNG). These oral products were surveyed in 2018 and 2019 from retail pharmacies, private and public health facilities, and the Area Medical Store, representing more than 90% of licensed medicine outlets. The product packaging was visually inspected, and the samples were analyzed for amoxicillin content using a validated high-performance liquid chromatography method. Although no falsified products were identified, 15% of the 190 products analyzed contained substandard amounts of amoxicillin. Quality varied with the dosage form (P = 0.002), with capsules exhibiting the lowest incidence of substandard content (4% in 2019) and tablets collected in 2018 experiencing the highest failure rate (50%). Suspension (40%) quality was compromised by failure to achieve homogeneity on reconstitution. A higher incidence of substandard content (P = 0.002) was associated with one major retail group. Routine testing of medicines by resource-poor countries is often unachievable, leading to the circulation of poor quality drugs, which is a global public health concern. Our study highlighted that substandard amoxicillin oral products are indeed prevalent in the NCD of PNG.

Author Notes

Address correspondence to Sherryl G. Robertson, Pharmacy, College of Medicine and Dentistry, James Cook University, 1 James Cook Drive, Townsville 4811, Australia. E-mail: sherryl.robertson@jcu.edu.au

Financial support: This study was financially supported by the College of Medicine and Dentistry, James Cook University, Australia via a Research Capacity Building Grant.

Authors’ addresses: Sherryl G. Robertson and Beverley D. Glass, Pharmacy, College of Medicine and Dentistry, James Cook University, Townsville, Australia, Emails: sherryl.robertson@jcu.edu.au and beverley.glass@jcu.edu.au. Naomi T. Hehonah and Rose D. Mayaune, Pharmacology, Division of Basic Medical Sciences, University of Papua New Guinea, Port Moresby, Papua New Guinea, E-mails: ntoleha.ali@gmail.com and rdmayaune@gmail.com.

Save